3.73
price down icon2.86%   -0.11
after-market Dopo l'orario di chiusura: 3.74 0.01 +0.27%
loading

Revance Therapeutics Inc Azioni (RVNC) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
25.59%
51.94
69.80 56.78 58.13 49.33
Operating Expenses
20.19%
98.76
123.75 196.07 123.63 107.36
Interest Income/Expense
2.63%
5.256
5.398 5.093 4.368 4.497
Benefits Costs and Expenses
101.46
- - - -
Costs And Expenses
18.01%
101.46
123.75 196.07 123.63 107.36
Depreciation and Amortization
18.78%
0.545
0.671 1.32 2.135 2.004
Operating Income/Loss
13.21%
-46.83
-53.95 -139.29 -65.50 -58.03
Income/Loss From Continuing Operations Before Tax
170.95%
-49.52
69.80 56.78 58.13 49.33
Income/Loss From Continuing Operations After Tax
11.08%
-49.52
-55.70 -141.18 -67.32 -59.79
Income/Loss From Discontinued Operations, Net Of Tax
-3.627
- - - -
Net Income/Loss
4.57%
-53.15
-55.70 -141.18 -67.32 -59.79
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
11,642%
91.92
0.7828 86.61 83.69 81.13
Diluted Average Shares
11,642%
91.92
0.7828 86.61 83.69 81.13
Basic Earnings Per Share
7.94%
-0.58
-0.63 -1.63 -0.80 -0.74
Diluted Earnings Per Share
7.94%
-0.58
-0.63 -1.63 -0.80 -0.74
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$71.72
price up icon 1.89%
$19.00
price up icon 3.15%
$41.11
price up icon 7.48%
$372.89
price up icon 1.51%
$190.51
price down icon 2.08%
$113.13
price up icon 4.53%
Capitalizzazione:     |  Volume (24 ore):